Oramed Pharmaceuticals
ORMP
#9108
Rank
C$0.11 B
Marketcap
$2.89
Share price
-3.33%
Change (1 day)
-23.41%
Change (1 year)

Revenue for Oramed Pharmaceuticals (ORMP)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of C$1.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Oramed Pharmaceuticals from 2009 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 C$1.77 M-51.54%
2022 C$3.66 M6.47%
2021 C$3.44 M-0.31%
2020 C$3.45 M-2.12%
2019 C$3.53 M3.17%
2018 C$3.42 M10.77%
2017 C$3.08 M83.75%
2016 C$1.68 M
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
C$0.79 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$59.55 BN/A๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
C$68.18 BN/A๐Ÿ‡ซ๐Ÿ‡ท France
C$39.61 MN/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
C$44.18 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA